Table 2.
Variables | Severe WMLs | p Value | |
---|---|---|---|
Yes, n =148 | No, n = 174 | ||
Demographic characteristics | |||
Age, years | 66.7 ± 12.5 | 63.0 ± 10.5 | 0.004 |
Male, n (%) | 89 (60.1) | 96 (55.2) | 0.369 |
Vascular risk factors, n (%) | |||
Hypertension | 113 (76.4) | 120 (69.0) | 0.140 |
Diabetes mellitus | 61 (41.2) | 66 (37.9) | 0.548 |
Hyperlipidemia | 17 (11.5) | 21 (12.1) | 0.872 |
Coronary heart disease | 30 (20.3) | 24 (13.8) | 0.121 |
Smoking | 61 (41.2) | 70 (40.2) | 0.857 |
Clinical data | |||
Previous statin therapy, n (%) | 48 (32.4) | 52 (29.9) | 0.622 |
Previous antiplatelet therapy, n (%) | 51 (34.5) | 50 (28.7) | 0.272 |
Systolic blood pressure, mmHg | 145.0 ± 24.4 | 137.9 ± 20.9 | 0.005 |
Diastolic blood pressure, mmHg | 83.4 ± 13.5 | 81.1 ± 11.9 | 0.106 |
Baseline NIHSS, score | 2.0 (0, 4.0) | 2.0 (0, 4.0) | 0.476 |
Stroke etiology, n (%) | 0.012 | ||
Large artery atherosclerosis | 81 (54.7) | 74 (42.5) | 0.029 |
Cardioembolic | 25 (16.9) | 21 (12.1) | 0.218 |
Small vessel occlusion | 32 (21.6) | 52 (29.9) | 0.092 |
Others | 10 (6.8) | 27 (15.5) | 0.014 |
Laboratory data | |||
Total cholesterol, mmol/L | 3.8 ± 0.9 | 3.9 ± 1.0 | 0.170 |
Triglyceride, mmol/L | 1.3 (1.0, 2.0) | 1.4 (1.1, 2.2) | 0.175 |
Low density lipoprotein, mmol/L | 1.9 (1.5, 2.5) | 2.1 (1.6, 2.6) | 0.147 |
High density lipoprotein, mmol/L | 1.0 (0.9, 1.2) | 1.0 (0.9, 1.2) | 0.278 |
Homocysteine, mmol/L | 15.1 ± 6.0 | 12.3 ± 4.3 | 0.001 |
Baseline blood glucose, mmol/L | 6.9 ± 2.3 | 6.8 ± 2.9 | 0.739 |
Hs-CRP, mg/L | 5.2 (2.6, 11.5) | 4.0 (1.3, 12.1) | 0.124 |
CitH3, ng/mL | 45.2 (17.8, 82.6) | 19.6 (10.3, 46.5) | 0.001 |
Abbreviations: CitH3, Citrullinated histone H3; Hs-CRP, hypersensitive C-reactive protein; NIHSS, National Institute of Health Stroke Scale; WMLs, white matter lesions. p indicated the statistical difference in the baseline data between groups. Informed consent was obtained from all subjects involved in the study. p indicated the statistical difference in the baseline data between groups.